Can expedited FDA drug approval without expedited follow-up be trusted?

JAMA Intern Med. 2014 Jan;174(1):95-7. doi: 10.1001/jamainternmed.2013.9202.

Author

Daniel Carpenter¹

Affiliation

¹ Department of Government and Center for American Political Studies, Radcliffe Institute for Advanced Study, Harvard University, Cambridge, Massachusetts.

PMID: 24165977
DOI: 10.1001/jamainternmed.2013.9202

No abstract available

Publication types

Comment

MeSH terms

Clinical Trials as Topic / statistics & numerical data*
Drug Approval / statistics & numerical data*
Drug Discovery / statistics & numerical data*
Humans
Product Surveillance, Postmarketing / statistics & numerical data*